Home/Filings/4/0001127602-25-002351
4//SEC Filing

Oosthuizen Johannes Jacobus 4

Accession 0001127602-25-002351

CIK 0000310158other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 6:23 PM ET

Size

5.1 KB

Accession

0001127602-25-002351

Insider Transaction Report

Form 4
Period: 2025-01-27
Oosthuizen Johannes Jacobus
President, U.S. Market
Transactions
  • Award

    Common Stock

    2025-01-27$97.94/sh+8,664$848,55232,607.474 total
Footnotes (2)
  • [F1]Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001916310

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:23 PM ET
Size
5.1 KB